Merck (CGRP programme Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Merck (CGRP programme Rights) General Information

Description

Migraine drugs for treatment and prevention of migraines. The receptor antagonists and oral calcitonin gene-related peptide is used for treatment of migraines.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Kenilworth, NJ
  • United States
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Allergan
Corporate Office
  • Kenilworth, NJ
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck (CGRP programme Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck (CGRP programme Rights)‘s full profile, request access.

Request a free trial

Merck (CGRP programme Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Merck (CGRP programme Rights)‘s full profile, request access.

Request a free trial

Merck (CGRP programme Rights) FAQs

  • Where is Merck (CGRP programme Rights) headquartered?

    Merck (CGRP programme Rights) is headquartered in Kenilworth, NJ.

  • What industry is Merck (CGRP programme Rights) in?

    Merck (CGRP programme Rights)’s primary industry is Buildings and Property.

  • Is Merck (CGRP programme Rights) a private or public company?

    Merck (CGRP programme Rights) is a Private company.

  • What is the current valuation of Merck (CGRP programme Rights)?

    The current valuation of Merck (CGRP programme Rights) is .

  • What is Merck (CGRP programme Rights)’s current revenue?

    The current revenue for Merck (CGRP programme Rights) is .

  • Who are Merck (CGRP programme Rights)’s investors?

    Merck & Co. has invested in Merck (CGRP programme Rights).

  • When was Merck (CGRP programme Rights) acquired?

    Merck (CGRP programme Rights) was acquired on 07-Jul-2015.

  • Who acquired Merck (CGRP programme Rights)?

    Merck (CGRP programme Rights) was acquired by Allergan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »